Cuu Long Pharmaceutical JSC (HOSE:DCL)
57,700
+100 (0.17%)
At close: Feb 9, 2026
HOSE:DCL Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 21,438 | 51,069 | 23,517 | 52,852 | 41,255 |
Short-Term Investments | 128,000 | 428.3 | 257.8 | 14,000 | 446,623 |
Trading Asset Securities | 104,795 | 104,795 | 94,795 | 94,795 | 70,270 |
Cash & Short-Term Investments | 254,233 | 156,292 | 118,570 | 161,647 | 558,148 |
Cash Growth | 62.67% | 31.81% | -26.65% | -71.04% | -39.31% |
Accounts Receivable | 279,746 | 305,669 | 272,178 | 224,627 | 176,980 |
Other Receivables | 366,185 | 384,812 | 431,418 | 444,704 | 134,123 |
Receivables | 645,931 | 690,481 | 703,596 | 669,332 | 311,103 |
Inventory | 360,376 | 345,751 | 365,031 | 315,080 | 308,196 |
Prepaid Expenses | 3,442 | 3,371 | 2,522 | 1,709 | 1,660 |
Other Current Assets | 101,237 | 236,114 | 213,406 | 274,478 | 82,048 |
Total Current Assets | 1,365,218 | 1,432,009 | 1,403,124 | 1,422,245 | 1,261,155 |
Property, Plant & Equipment | 1,037,272 | 949,575 | 834,368 | 649,459 | 491,030 |
Other Intangible Assets | -3,103 | 23,117 | 23,316 | 20,984 | 21,151 |
Long-Term Deferred Tax Assets | -1,600 | 3,389 | 4,881 | 5,932 | 2,421 |
Other Long-Term Assets | 22,773 | 16,056 | 11,770 | 6,703 | 5,271 |
Total Assets | 2,420,559 | 2,424,146 | 2,277,460 | 2,105,323 | 1,781,028 |
Accounts Payable | 67,530 | 105,264 | 66,129 | 36,751 | 31,117 |
Accrued Expenses | 29,016 | 40,531 | 46,175 | 51,674 | 30,943 |
Short-Term Debt | 551,234 | 394,064 | 349,732 | 288,008 | 361,270 |
Current Portion of Long-Term Debt | - | 70,266 | 51,646 | 62,406 | 32,466 |
Current Portion of Leases | - | 24,544 | 20,758 | 3,580 | - |
Current Income Taxes Payable | - | 13,083 | 14,908 | 12,558 | 5,681 |
Other Current Liabilities | 24,295 | 7,233 | 68,726 | 99,090 | 249,752 |
Total Current Liabilities | 672,073 | 654,984 | 618,075 | 554,068 | 711,229 |
Long-Term Debt | 227,201 | 265,969 | 208,593 | 159,598 | 106,561 |
Total Liabilities | 899,275 | 920,953 | 826,668 | 713,666 | 817,790 |
Common Stock | 730,410 | 730,410 | 730,410 | 730,410 | 588,328 |
Additional Paid-In Capital | 220,359 | 220,359 | 220,359 | 220,359 | 7,236 |
Retained Earnings | 550,924 | 533,388 | 481,561 | 422,844 | 316,282 |
Comprehensive Income & Other | - | 20.17 | 20.17 | 20.17 | 20.17 |
Total Common Equity | 1,501,694 | 1,484,177 | 1,432,350 | 1,373,633 | 911,866 |
Minority Interest | 19,591 | 19,016 | 18,441 | 18,024 | 51,372 |
Shareholders' Equity | 1,521,284 | 1,503,193 | 1,450,792 | 1,391,657 | 963,238 |
Total Liabilities & Equity | 2,420,559 | 2,424,146 | 2,277,460 | 2,105,323 | 1,781,028 |
Total Debt | 778,435 | 754,843 | 630,730 | 513,592 | 500,297 |
Net Cash (Debt) | -524,202 | -598,551 | -512,160 | -351,945 | 57,851 |
Net Cash Growth | - | - | - | - | -66.40% |
Net Cash Per Share | -7171.46 | -8194.72 | -7011.95 | -5016.29 | 1006.12 |
Filing Date Shares Outstanding | 73.15 | 73.04 | 73.04 | 73.04 | 58.83 |
Total Common Shares Outstanding | 73.15 | 73.04 | 73.04 | 73.04 | 58.83 |
Working Capital | 693,145 | 777,026 | 785,049 | 868,177 | 549,927 |
Book Value Per Share | 20528.97 | 20319.77 | 19610.21 | 18806.32 | 15499.27 |
Tangible Book Value | 1,504,797 | 1,461,060 | 1,409,034 | 1,352,649 | 890,715 |
Tangible Book Value Per Share | 20571.40 | 20003.28 | 19291.00 | 18519.03 | 15139.76 |
Buildings | - | 230,984 | 181,452 | 181,452 | 184,154 |
Machinery | - | 708,703 | 702,704 | 693,570 | 710,381 |
Construction In Progress | 231,850 | 514,261 | 416,779 | 206,222 | 25,712 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.